Inhibition of miR-330-3p prevent DSS-induced ulcerative colitis and cell apoptosis and increased XBP1 expression, suggesting that miR-330-3p might be a diagnostic biomarker of ulcerative colitis, and that XBP1 could be a potential therapeutic target for ulcerative colitis. The gene discussed is XBP1; the disease is ulcerative colitis.